HealthCare Market Analysis

Global  eHealth market  is expected to reach USD 308.0 billion by 2022, according to a new report by Grand View Research Inc. The transition of the healthcare industry into digital healthcare system for management and analysis of patient health is expected to be the most vital driver of the market. Increasing prevalence of chronic diseases, and technological advancements in this field are few impact rendering factors. Rising use of mobile technologies and internet along with increasing adoption for home care by patients is expected to propel market growth over the forecast period. North America eHealth market, by product, 2012-2022 (USD Million) Furthermore, expanding scope of IT companies pertaining to the development of real-time applications and software catering to the healthcare industry is expected to drive demand over the forecast period. Federal agencies such as the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (

The global  reprocessed medical devices market  is expected to reach USD 5.0 billion by 2022, according to a new study by Grand View Research, Inc. The increasing generation of medical waste coupled with the lack of centralized support for waste disposal in the healthcare industry is expected to drive the demand for reprocessed medical devices market. Additionally, the long-term cost-efficiency associated with these devices as compared to that of the original device is the high impact rendering driver of the industry.  According to the Association of Medical Device Reprocessors (AMDR),hospitals witness up to 50% cost saving on every purchase of the reprocessed medical device, thereby spending only a limited amount, on waste disposal.  Consequentially, reprocessing has also facilitated reduction in device cost by the original equipment manufacturer in a vain to compete with the third-party reprocessors, thus exerting a positive cumulative effect on the industry growth.  Fur

The global  ventricular assist device market  is expected to reach USD 1.97 billion by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to its rapid growth include rising prevalence of cardiovascular disorders coupled with the development of technological advanced products such as miniature device with infection reduction technology.  Furthermore, increasing healthcare expenditure, favorable reimbursement policies and advanced technological facilities, are expected to positively reinforce ventricular assist device market growth over the next seven years.  Ventricular assist device market is segmented on the basis of type of product which includes left ventricular, right ventricular and bi-ventricular assist device. Key factors attributing to rapidly increasing number of patients with end stage heart failure and low availability of therapeutic options are among the key factors attributing to the market growth.  U.S. ventricular assist